Antibiotic Resistance and Nanotherapy
- 1st Edition - February 7, 2026
- Latest edition
- Editors: Awanish Kumar, Sharda Bharti
- Language: English
Antibiotic Resistance and Nanotherapy is a comprehensive guide that explores an interdisciplinary approach to address the pressing issue of antibiotic resistance and explor… Read more
Antibiotic Resistance and Nanotherapy is a comprehensive guide that explores an interdisciplinary approach to address the pressing issue of antibiotic resistance and explores the possibility of nanotherapy as a cutting-edge strategy to treat illnesses that are resistant to antibiotics, employing nanoparticles to target and kill bacteria selectively without damaging healthy cells. It details the underlying mechanisms of drug resistance in intracellular and extracellular pathogens and explores the latest advancements in nanotechnology, including the development of innovative nanomaterials and delivery systems that can be utilized to combat antibiotic-resistant infections. This book also discusses the ethical and practical challenges associated with implementing nanotherapy for bacterial resistance. Featuring contributions from experts in the field, this book is an essential resource for researchers, medical professionals, and policymakers seeking to understand and tackle the immediate threat posed by antibiotic resistance.
- Examines the current state of antimicrobial resistance, its impact on global health, and the rise of drug-resistant "superbugs"
- Demonstrates how nanotherapeutics using diverse nanoparticles can be used to address antibiotic resistance
- Provides in-depth discussions of the mechanisms underlying antibiotic resistance, the prospect of antibiotic-resistant infection treatments based on nanotechnology, and the most recent developments in nanotechnology-based diagnostics
Researchers, academics, industry professionals, and graduate-level students in the field of microbiology, nanotechnology, biotechnology, infectious diseases biomedical sciences; clinicians treating microbial diseases
1. Introduction to planktonic and biofilm-mediated antimicrobial
resistance and role of nanotechnology in overcoming biofilm-mediated
antibiotic resistance
2. Key determinants of antimicrobial resistance: exploring the influence of
antibiotic pollution on the emergence of multidrug-resistant microbes
3. Drug resistance mechanism in intracellular pathogens and modulation
4. Metal-based nanomedicine against intracellular pathogens
5. Lipid-based nanomedicine against intracellular pathogens
6. Metal-based nanomedicine against extracellular pathogens
7. Polymer-based nanomedicine against extracellular pathogens
8. Lipid-based nanomedicine against extracellular pathogens
9. Interaction between infected host cells and nanodelivery systems
10. Innovative strategies utilizing nanoparticles to disrupt c-di-GMP and
quorum-sensing signaling pathways to combat antibiotic resistance
induced by biofilms
11. CRISPR-Cas systems for antibiotic resistance
12. Synergistic effects of natural compounds and repurposed drugs in
nanotherapy: a strategy to combat biofilm-associated infections
13. Safety, ethical, regulatory issues, and challenges of nanotherapy for
antimicrobial resistance
resistance and role of nanotechnology in overcoming biofilm-mediated
antibiotic resistance
2. Key determinants of antimicrobial resistance: exploring the influence of
antibiotic pollution on the emergence of multidrug-resistant microbes
3. Drug resistance mechanism in intracellular pathogens and modulation
4. Metal-based nanomedicine against intracellular pathogens
5. Lipid-based nanomedicine against intracellular pathogens
6. Metal-based nanomedicine against extracellular pathogens
7. Polymer-based nanomedicine against extracellular pathogens
8. Lipid-based nanomedicine against extracellular pathogens
9. Interaction between infected host cells and nanodelivery systems
10. Innovative strategies utilizing nanoparticles to disrupt c-di-GMP and
quorum-sensing signaling pathways to combat antibiotic resistance
induced by biofilms
11. CRISPR-Cas systems for antibiotic resistance
12. Synergistic effects of natural compounds and repurposed drugs in
nanotherapy: a strategy to combat biofilm-associated infections
13. Safety, ethical, regulatory issues, and challenges of nanotherapy for
antimicrobial resistance
- Edition: 1
- Latest edition
- Published: February 7, 2026
- Language: English
AK
Awanish Kumar
Dr. Awanish Kumar is an Associate Professor of the Department of Biotechnology at the National Institute of Technology, Raipur, Chhattisgarh, India. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery.
Affiliations and expertise
Associate Professor and Head, Department of Biotechnology, National Institute of Technology Raipur, IndiaSB
Sharda Bharti
Dr. Sharda Bharti is an Assistant Professor in the Department of Biotechnology at the National Institute of Technology (NIT), Raipur, India, an institute of national Importance under the Ministry of Education, Government of India. She completed her MTech and PhD in environmental science and engineering from the Indian Institute of Technology (IIT) Bombay, Mumbai, India. Her research interests primarily focus on the application of nanomaterials in water disinfection, water and wastewater treatment, antimicrobial resistance, and environmental health and safety.
Affiliations and expertise
Assistant Professor, Department of Biotechnology, National Institute of Technology, Raipur, India